Eliem Therapeutics Competitors and Similar CompaniesClear all
Eliem Therapeutics's competitors and similar companies include GBT (Global Blood Therapeutics), United Biomedical, Novoron Bioscience and Phoenix Tissue Repair.
 Eliem Therapeutics Eliem Therapeutics is a company developing therapeutics intended to treat neuronal excitability disorders. |  GBT (Global Blood Therapeutics) GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need. |  United Biomedical United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases. |  Novoron Bioscience Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate the nerves of the central nervous system. |  Phoenix Tissue Repair Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa. | |
Founding Date | Founding Date 2018 | Founding Date 2012 | Founding Date 1985 | Founding Date 2013 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Redmond, US HQ Altrincham, GB | Locations South San Francisco, US HQ Paris, FR Berlin, DE Baar, CH London, GB | Locations San Diego, US HQ San Diego, US | Locations Boston, US HQ | |
Employees | Employees 9200% increase | Employees 352106% increase | Employees 45 | Employees 166% decrease | Employees 5 |
Valuation ($) | Valuation ($) 342.7 m | Valuation ($) 4.4 b | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Net income | Net income ($59.9m) (FY, 2025) | Net income ($303.1m) (FY, 2021) | Net income N/A | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 171.3m | Total funding raised $ 88.7m | Total funding raised N/A | Total funding raised $ 1.3m | Total funding raised N/A |
For sources of this data, please see the company profile
View Company Profiles
GBT (Global Blood Therapeutics)
HQ
South San Francisco, US
Employees
352
GBT (Global Blood Therapeutics) is a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing novel therapeutics to treat grievous blood-based disorders with significant unmet need.
View companyUnited Biomedical
HQ
Hauppauge, US
Employees
45
United Biomedical is a biopharmaceutical company dedicated to the discovery, development, and commercialization of immunotherapeutics and vaccines for chronic and infectious diseases.
View companyNovoron Bioscience
HQ
San Diego, US
Employees
16↓ 6% decrease
Novoron Bioscience is a biotechnology company that develops pharmaceutical therapies to regenerate the nerves of the central nervous system.
View companyPhoenix Tissue Repair
HQ
Boston, US
Phoenix Tissue Repair is a company specializing in the development of treatment for recessive dystrophic epidermolysis bullosa.
View company